Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Research and development	$ (233)	$ (65)
General and administrative	(160)	(92)
Operating loss	(393)	(157)
Financial income (expenses), net	77	578
Net income (loss)	(316)	421
Non-controlling interests	130	27
Net income (loss) attributable to equity holders of the Company	$ (186)	$ 448
Basic and diluted net income (loss) per share attributable to equity holders of the Company (in Dollars per share)	$ (0.04)	$ 0.11
Weighted average number of ordinary shares used in computing basic and diluted loss per share (in Shares)	4,215,571	4,194,385